211 related articles for article (PubMed ID: 29628759)
1. The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Patel NR; Cunoosamy DM; Fagerås M; Taib Z; Asimus S; Hegelund-Myrbäck T; Lundin S; Pardali K; Kurian N; Ersdal E; Kristensson C; Korsback K; Palmér R; Brown MN; Greenaway S; Siew L; Clarke GW; Rennard SI; Make BJ; Wise RA; Jansson P
Int J Chron Obstruct Pulmon Dis; 2018; 13():1009-1019. PubMed ID: 29628759
[TBL] [Abstract][Full Text] [Related]
2. Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells.
Higham A; Karur P; Jackson N; Cunoosamy DM; Jansson P; Singh D
Int J Chron Obstruct Pulmon Dis; 2018; 13():1279-1288. PubMed ID: 29719383
[TBL] [Abstract][Full Text] [Related]
3. AZD7624, an Inhaled p38 Inhibitor, Demonstrates Local Lung Inhibition of LPS-Induced TNF
Pehrson R; Hegelund-Myrbäck T; Cunoosamy D; Asimus S; Jansson P; Patel N; Borde A; Lundin S
J Pharmacol Exp Ther; 2018 Jun; 365(3):567-572. PubMed ID: 29549158
[TBL] [Abstract][Full Text] [Related]
4. Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD.
Pascoe S; Costa M; Marks-Konczalik J; McKie E; Yang S; Scherbovsky PS
Respir Med; 2017 Sep; 130():20-26. PubMed ID: 29206629
[TBL] [Abstract][Full Text] [Related]
5. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM; Beier J; Candler H; Wittig T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2877-2884. PubMed ID: 27920515
[TBL] [Abstract][Full Text] [Related]
6. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages.
Smith SJ; Fenwick PS; Nicholson AG; Kirschenbaum F; Finney-Hayward TK; Higgins LS; Giembycz MA; Barnes PJ; Donnelly LE
Br J Pharmacol; 2006 Oct; 149(4):393-404. PubMed ID: 16953188
[TBL] [Abstract][Full Text] [Related]
8. Phase II Study of Single/Repeated Doses of Acumapimod (BCT197) to Treat Acute Exacerbations of COPD.
Strâmbu IR; Kobalava ZD; Magnusson BP; MacKinnon A; Parkin JM
COPD; 2019 Dec; 16(5-6):344-353. PubMed ID: 31682162
[TBL] [Abstract][Full Text] [Related]
9. Dual Role For A MEK Inhibitor As A Modulator Of Inflammation And Host Defense Mechanisms With Potential Therapeutic Application In COPD.
Kurian N; Cohen TS; Öberg L; De Zan E; Skogberg G; Vollmer S; Baturcam E; Svanberg P; Bonn B; Smith PD; Vaarala O; Cunoosamy DM
Int J Chron Obstruct Pulmon Dis; 2019; 14():2611-2624. PubMed ID: 32063702
[TBL] [Abstract][Full Text] [Related]
10. Increased activation of p38 MAPK in COPD.
Renda T; Baraldo S; Pelaia G; Bazzan E; Turato G; Papi A; Maestrelli P; Maselli R; Vatrella A; Fabbri LM; Zuin R; Marsico SA; Saetta M
Eur Respir J; 2008 Jan; 31(1):62-9. PubMed ID: 17959643
[TBL] [Abstract][Full Text] [Related]
11. Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs.
Gaffey K; Reynolds S; Plumb J; Kaur M; Singh D
Eur Respir J; 2013 Jul; 42(1):28-41. PubMed ID: 23060629
[TBL] [Abstract][Full Text] [Related]
12. In vitro modeling of COPD inflammation and limitation of p38 inhibitor - SB203580.
Meng A; Zhang X; Wu S; Wu M; Li J; Yan X; Kopec-Harding K; Wu J
Int J Chron Obstruct Pulmon Dis; 2016; 11():909-17. PubMed ID: 27199554
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients.
Singh D; Smyth L; Borrill Z; Sweeney L; Tal-Singer R
J Clin Pharmacol; 2010 Jan; 50(1):94-100. PubMed ID: 19880675
[TBL] [Abstract][Full Text] [Related]
14. Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
Lo CY; Huang HY; He JR; Huang TT; Heh CC; Sheng TF; Chung KF; Kuo HP; Wang CH
Int J Chron Obstruct Pulmon Dis; 2018; 13():1135-1144. PubMed ID: 29692608
[TBL] [Abstract][Full Text] [Related]
15. Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives.
Pelaia C; Vatrella A; Sciacqua A; Terracciano R; Pelaia G
Expert Rev Respir Med; 2020 May; 14(5):485-491. PubMed ID: 32077346
[No Abstract] [Full Text] [Related]
16. Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease.
Pinner NA; Hamilton LA; Hughes A
Clin Ther; 2012 Jan; 34(1):56-66. PubMed ID: 22284994
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial.
Watz H; Barnacle H; Hartley BF; Chan R
Lancet Respir Med; 2014 Jan; 2(1):63-72. PubMed ID: 24461903
[TBL] [Abstract][Full Text] [Related]
18. Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD.
Moretti M; Fagnani S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2319-25. PubMed ID: 26604731
[TBL] [Abstract][Full Text] [Related]
19. RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-α and -γ selectivity, suppresses COPD inflammation.
Charron CE; Russell P; Ito K; Lea S; Kizawa Y; Brindley C; Singh D
Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29074542
[TBL] [Abstract][Full Text] [Related]
20. A post-hoc subgroup analysis of data from a six month clinical trial comparing the efficacy and safety of losmapimod in moderate-severe COPD patients with ≤2% and >2% blood eosinophils.
Marks-Konczalik J; Costa M; Robertson J; McKie E; Yang S; Pascoe S
Respir Med; 2015 Jul; 109(7):860-9. PubMed ID: 26033641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
